The serum concentrations of VEGF significantly decreased in the NPDR group 1 week and 1 month post-injection compared to the pre-injection baseline values (P = 0.005 and P = 0.009, respectively) (Fig. 1A, Table 4). Here, VEGFA is linked to non-proliferative diabetic retinopathy.